Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Biopsafe ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.3% 1.3% 1.3% 1.3% 1.3% 1.3% 1.3% 1.3%   Bankruptcy risk   2.4% 1.5% 1.6% 1.5% 1.4% 2.0% 6.5% 6.5%   Credit score (0-100)   65 77 75 75 77 67 36 36   Credit rating   BBB A A A A A BBB BBB   Credit limit (kDKK)   0.0 17.1 10.8 26.6 46.8 0.9 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   3,703 6,340 5,209 4,605 6,081 7,235 0.0 0.0   EBITDA   260 803 619 3,443 4,685 3,325 0.0 0.0   EBIT   260 803 619 582 2,658 919 0.0 0.0   Pre-tax profit (PTP)   37.7 348.5 294.5 331.0 1,892.0 130.0 0.0 0.0   Net earnings   37.7 268.2 219.0 250.0 1,447.0 79.0 0.0 0.0   Pre-tax profit without non-rec. items   37.7 349 295 331 1,892 131 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   16,435 15,418 15,556 14,077 13,054 12,043 0.0 0.0   Shareholders equity total   3,513 3,781 4,000 4,250 5,698 5,079 3,992 3,992   Interest-bearing liabilities   20,944 18,319 17,951 15,518 15,205 12,389 0.0 0.0   Balance sheet total (assets)   29,261 27,125 26,221 24,323 26,671 22,748 3,992 3,992   Net Debt   20,606 17,569 17,441 11,805 15,205 12,389 -2,761 -2,761     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   3,703 6,340 5,209 4,605 6,081 7,235 0.0 0.0   Gross profit growth   -19.1% 71.2% -17.8% -11.6% 32.1% 19.0% -100.0% 0.0%   Employees   1 1 3 3 2 4 0 0   Employee growth %   0.0% 0.0% 200.0% 0.0% -33.3% 100.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   29,261 27,125 26,221 24,323 26,671 22,748 3,992 3,992   Balance sheet change%   1.4% -7.3% -3.3% -7.2% 9.7% -14.7% -82.5% 0.0%   Added value   259.7 802.5 618.7 3,443.0 5,519.0 3,325.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   1,327 -1,804 -983 -5,722 -4,054 -4,602 -12,043 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   7.0% 12.7% 11.9% 12.6% 43.7% 12.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   1.1% 2.8% 2.3% 2.3% 10.4% 4.1% 0.0% 0.0%   ROI %   1.2% 3.0% 2.4% 2.4% 11.5% 4.6% 0.0% 0.0%   ROE %   1.1% 7.4% 5.6% 6.1% 29.1% 1.5% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   12.0% 13.9% 15.3% 17.5% 21.4% 22.3% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   7,933.7% 2,189.3% 2,819.0% 342.9% 324.5% 372.6% 0.0% 0.0%   Gearing %   596.2% 484.5% 448.8% 365.1% 266.8% 243.9% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   1.4% 2.3% 1.8% 1.5% 5.0% 6.3% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.2 0.2 0.2 0.4 1.1 0.7 0.0 0.0   Current Ratio   0.3 0.3 0.3 0.4 1.3 1.1 0.0 0.0   Cash and cash equivalent   337.9 749.7 510.4 3,713.0 0.0 0.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -13,648.2 -12,378.6 -13,110.9 -10,292.0 2,753.0 938.0 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   260 803 206 1,148 2,760 831 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   260 803 206 1,148 2,343 831 0 0   EBIT / employee   260 803 206 194 1,329 230 0 0   Net earnings / employee   38 268 73 83 724 20 0 0